信息

信息
GEXVal CTO to Present at the Annual Meeting of the PSJ
2026年3月25日

株式會社GEXValMarch 25, 2026 GEXVal CTO to Present at the 146th Annual Meeting of the Pharmaceutical Society of Ja […]

Read more
信息
CTO Nakayama Contributes Invited Article to Experimental Medicine, Japan’s Leading Life Science Journal, on AI-Driven Drug Discovery
2026年3月12日

株式會社GEXValMarch 12, 2026 CTO Nakayama Contributes Invited Article to Experimental Medicine Special Issue on AI […]

Read more
信息
Rare Disease Day Update: FRAXA Features GEXVal’s FRAXA-DVI Completion and FDA Orphan Drug Designation
2026年2月28日

株式會社GEXValFebruary 28, 2026 FRAXA Research Foundation Features GEXVal's Completion of FRAXA-DVI Program and FD […]

Read more
信息
GEXVal Selected as Presenting Company at Biotech Showcase™ 2026
2026年1月7日

株式會社GEXValJanuary 7, 2026 GEXVal Selected as Presenting Company at Biotech Showcase™ 2026 GEXVal Inc. (Preside […]

Read more
信息
GEXVal Featured in BioCentury Article
2025年12月22日

株式會社GEXValDecember 22, 2025 GEXVal Featured in BioCentury Article “Raising the Sun: Japan Biotech Looks to Lev […]

Read more